Related Experiment Video

Updated: Jan 5, 2026

An In Vitro Model for Studying Cellular Transformation by Kaposi Sarcoma Herpesvirus
09:53

An In Vitro Model for Studying Cellular Transformation by Kaposi Sarcoma Herpesvirus

Published on: August 25, 2017

9.3K

The Regulatory Effects of CDKN1A on Relevant Genes in Kaposi's Sarcoma Cells

Jing Zhang1, Xiong-Ming Pu2, Xiu-Juan Wu2

  • 1Affiliated Traditional Chinese Medicine Hospital, Xinjiang Medical University, Uygur Autonomous Region, Urumqi, China 565992809@qq.com.

Annals of Clinical and Laboratory Science
|October 16, 2019
PubMed

Insights

The cyclin-dependent kinase inhibitor 1A (CDKN1A) gene negatively regulates key cell cycle genes in Kaposi's Sarcoma (KS). This finding suggests CDKN1A may be a potential therapeutic target for KS development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Virology

Background:

  • The cyclin-dependent kinase inhibitor 1A (CDKN1A) gene is implicated in various cancers.
  • Its specific role and regulatory mechanisms in Kaposi's Sarcoma (KS) remain largely uncharacterized.

Purpose of the Study:

  • To investigate the regulatory impact of CDKN1A on specific genes within KS cells.
  • To elucidate the role of CDKN1A in the pathogenesis of Kaposi's Sarcoma.

Main Methods:

  • Kaposi's Sarcoma cells were transfected with CDKN1A overexpression vectors or siRNA.
  • Western Blot (WB) and quantitative real-time polymerase chain reaction (q-PCR) were employed.
  • Expression levels of CyclinD1, CyclinE, and kshv-mir-k12-1-5p were assessed.

Main Results:

  • CDKN1A was found to negatively regulate the expression of CyclinD1 and CyclinE.
  • CDKN1A also negatively modulated the expression of kshv-mir-k12-1-5p.
  • These regulatory effects were observed in KS cells following CDKN1A manipulation.

Conclusions:

  • CDKN1A plays a role in Kaposi's Sarcoma development by regulating kshv-mir-k12-1-5p, CyclinD1, and CyclinE.
  • CDKN1A presents a potential novel target for therapeutic interventions in KS.
Keywords:
CDKN1ACyclinD1CyclinEKaposi’s Sarcomakshv-mir-k12-1-5p

More Related Videos

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus KSHV07:02

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus KSHV

Published on: September 14, 2010

13.0K
Quantitative Fluorescence In Situ Hybridization FISH and Immunofluorescence IF of Specific Gene Products in KSHV-Infected Cells06:21

Quantitative Fluorescence In Situ Hybridization FISH and Immunofluorescence IF of Specific Gene Products in KSHV-Infected Cells

Published on: August 27, 2019

13.0K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.2K
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
6.4K
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
133.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.2K